AAL

Hims and Hers Health Stock Testing Key Trendline

HIMS is more than 20% off its late-November record high

Managing Editor
Dec 19, 2024 at 3:39 PM
facebook X logo linkedin


Hims & Hers Health Inc (NYSE:HIMS) stock is sitting out the broad market rally today, last seen down 8.4% to trade at $26.15. The personalized healthcare company -- a key player in the weight loss drug craze -- is taking a hit after the Food and Drug Administration (FDA) announced Eli Lilly's (LLY) weight-loss drug shortage was resolved. 

HIMS is on track for its worst single-session decline since Nov. 14, when Amazon.com (AMZN) entered the telehealth services fray. The shares have taken an over 20% haircut since a Nov. 27 record high of $35.02 and are testing newfound support at their 50-day moving average, which emerged last month. Year to date, the equity is 189.9% higher. 

HIMS Stock

Short sellers keep piling on, with short interest up 25.9% in the most recent reporting period. The 42.62 million shares sold short account for 23.1% of HIMS' total available float. Upgrade potential is there, too, with nine of 14 brokerages in coverage sporting "hold" or worse ratings.

It's also worth noting that the stock has consistently outperformed volatility expectations in the last 12 months, as reflected in its Schaeffer’s Volatility Scorecard (SVS) score of 91 out of 100.

 

Same-Day Trading Power: +227% YTD and Counting  — Get in for $10!

We're celebrating 44 years of helping traders win, and you can now tap into one of our most explosive services — Dynamite Day Trading Signals — for just $10.

This service was built for one thing: capturing intraday gains with precision. 

Access two highly-vetted options trades each week -  Complete with defined entries, exits, and a clear plan for same-day profits.

👉 Click Here to Learn More and Position Yourself to Take Action When the Next Alert Hits.